EPTAM Precision’s approach is designed to help medical manufacturers scale increasingly complex products by emphasizing earlier cross-functional integration.
NORTHFIELD, N.H.—As medical device and biotech innovations continue to accelerate, manufacturers are confronted by the challenges of rising product complexity, compressed commercialization timelines, intensifying regulatory scrutiny, and ongoing global supply chain volatility. Scaling from prototype to full production has become one of the most critical and risk-prone phases of the product lifecycle, according to a release from EPTAM Precision.
EPTAM recently developed and implemented a new company-wide operational philosophy, “Reliability Requires Rhythm,” designed to strengthen new product introduction and transfer execution while ensuring scalable, repeatable manufacturing performance in complex medical markets. The launch of its new philosophy, according to EPTAM, reinforces the company’s commitment to “helping medical manufacturers bring increasingly complex products to scale with greater control, repeatability, and operational resilience.”
The company partners with medical OEMs to industrialize complex components and assemblies through precision plastic injection molding, liquid silicone rubber molding, advanced plastic and metal machining, micro-machining, and automated production and inspection systems. EPTAM supports programs from early design collaboration through validated, high-volume manufacturing.
“We’re seeing more transfer programs across the market, with many challenges emerging during scale,” said EPTAM Vice President of Commercial Development Mary Jo Sysko, in a company release. “Reliability isn’t something you inspect into a process at the end. It requires alignment across engineering, automation, production, and quality from the start.”
The company’s “Rhythm” philosophy formalizes that alignment through earlier cross-functional integration, structured verification milestones, and tighter coordination between design-for-manufacturing, tooling development, automation, and quality systems. By validating critical inputs before accelerating volume, EPTAM aims to reduce variability, protect design intent, and minimize disruption during validation and ramp.
“Verification beats confidence,” said EPTAM Chief Operating Officer Steve Cardin, in the release. “When programs scale, small disconnects become large problems. ‘Rhythm’ is about eliminating those disconnects before they affect production.”
The approach spans EPTAM’s precision plastic injection molding, liquid silicone rubber molding, plastic machining, metal machining and micro-machining, and automated production and inspection systems. Automation is positioned not as a speed tool alone, but as a mechanism to reduce variability and reinforce quality.
EPTAM Precision Solutions manufactures high-precision components and assemblies for the medical device, biotech, and advanced technology markets. “With deep expertise across plastics, metals, liquid silicone rubber, and automated manufacturing, EPTAM partners with medtech innovators to bring complex designs from concept through scalable production with confidence,” the release stated.
[raw]